Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net: 2014-2021

Historic Receivables - Net for Viridian Therapeutics, Inc.\DE (VRDN) over the last 7 years, with Sep 2021 value amounting to $1.0 million.

  • Viridian Therapeutics, Inc.\DE's Receivables - Net rose 1654.39% to $1.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 million, marking a year-over-year increase of 1654.39%. This contributed to the annual value of $24,000 for FY2018, which is 98.35% down from last year.
  • Per Viridian Therapeutics, Inc.\DE's latest filing, its Receivables - Net stood at $1.0 million for Q3 2021, which was up 1,654.39% from $57,000 recorded in Q3 2020.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Net registered a high of $4.8 million during Q1 2018, and its lowest value of $4,000 during Q1 2020.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Receivables - Net averaged around $374,143, with its median value being $248,000 (2020).
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Receivables - Net soared by 7,180.00% in 2017, and later slumped by 99.88% in 2019.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Net (Quarterly) stood at $1.5 million in 2017, then plummeted by 98.35% to $24,000 in 2018, then declined by 29.16% to $979,000 in 2019, then tumbled by 94.18% to $57,000 in 2020, then spiked by 1,654.39% to $1.0 million in 2021.
  • Its Receivables - Net was $1.0 million in Q3 2021, compared to $57,000 in Q3 2020 and $248,000 in Q2 2020.